These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1523610)

  • 21. Factors affecting prostaglandin endoperoxide transformation: antibodies against PGH2.
    Fitzpatrick FA; Pike JE
    Prog Lipid Res; 1981; 20():179-82. PubMed ID: 7342082
    [No Abstract]   [Full Text] [Related]  

  • 22. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
    Patscheke H; Stegmeier K
    Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased platelet aggregation due to chilling to 20 degrees C is not related to increased sensitivity to agonists.
    Hansen TN; Brockbank KG
    Transfusion; 1997 Jul; 37(7):696-702. PubMed ID: 9225932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arachidonate is an antagonist of platelet activation by the endoperoxide analog U46619.
    Huang EM; Detwiler TC
    Biochim Biophys Acta; 1982 Apr; 715(2):246-9. PubMed ID: 6803846
    [No Abstract]   [Full Text] [Related]  

  • 25. Role of thromboxane A2.
    Ambler J; Birch J; Maguire ED; Wallis RB
    Adv Exp Med Biol; 1985; 192():293-308. PubMed ID: 2939695
    [No Abstract]   [Full Text] [Related]  

  • 26. The inhibition of arachidonic acid metabolism in human platelets by RHC 80267, a diacylglycerol lipase inhibitor.
    Oglesby TD; Gorman RR
    Biochim Biophys Acta; 1984 Apr; 793(2):269-77. PubMed ID: 6424715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Succinate potentiates the action of platelet agonists.
    Huang EM; McGowan EB; Detwiler TC
    Thromb Res; 1984 Oct; 36(1):1-8. PubMed ID: 6095483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of ethanol on pathways of platelet aggregation in vitro.
    Rand ML; Packham MA; Kinlough-Rathbone RL; Fraser Mustard J
    Thromb Haemost; 1988 Jun; 59(3):383-7. PubMed ID: 3142075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of thromboxane receptors in human platelets.
    Jones RL; Wilson NH; Armstrong RA
    Adv Exp Med Biol; 1985; 192():67-81. PubMed ID: 3010674
    [No Abstract]   [Full Text] [Related]  

  • 30. Nitroprusside inhibits platelet function primarily by inhibiting Ca2+ mobilization.
    Krishnamurthi S; Wheeler-Jones CP; Patel Y; Sadowska K; Kakkar VV; Rao GH
    Biochem Soc Trans; 1990 Jun; 18(3):468-9. PubMed ID: 2115470
    [No Abstract]   [Full Text] [Related]  

  • 31. PgH2 analogs as potential antiplatelet derivatives.
    Komiotis D; Lim CT; Dieter JP; Le Breton GC; Venton DL
    J Med Chem; 1992 Aug; 35(16):3033-9. PubMed ID: 1501231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potent antiplatelet effects of cyclic clofibric acid (CPIB) analogs on human platelets.
    Romstedt KJ; Kim SU; Witiak DT; Newman HA; Feller DR
    Thromb Res; 1989 May; 54(4):289-99. PubMed ID: 2503906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decrease of platelet aggregation and spreading via inhibition of the cAMP phosphodiesterase by trapidil.
    Mazurov AV; Menshikov MYu ; Leytin VL; Tkachuk VA; Repin VS
    FEBS Lett; 1984 Jul; 172(2):167-71. PubMed ID: 6086387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Desensitisation of human platelets against stimulation by thromboxane mimics--reduction in receptor capacity and loss of functional response.
    Thierauch KH; Gabriel D; Prior G; Schillinger E
    Biomed Biochim Acta; 1988; 47(10-11):S75-8. PubMed ID: 2470362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversal of thromboxane A2/prostaglandin H2 and ADP-induced calcium release in intact platelets.
    Brace LD; Venton DL; Le Breton GC
    Am J Physiol; 1985 Jul; 249(1 Pt 2):H8-13. PubMed ID: 2409821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thromboxane A2/prostaglandin H2 mobilizes calcium in human blood platelets.
    Brace LD; Venton DL; Le Breton GC
    Am J Physiol; 1985 Jul; 249(1 Pt 2):H1-7. PubMed ID: 3925795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of combination therapy with low-dose aspirin and warfarin on platelet functions after heart valve replacement.
    Kobune K; Inoue M; Morikawa M; Tsuboi M; Takanami Y; Iwane Y; Kudo T
    Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):153-65. PubMed ID: 1811279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Total and selective desensitisation of human platelets to synthetic platelet activating factor (PAF): evidence that extracellular PAF does not mediate collagen-induced aggregation.
    Nunn B
    Thromb Res; 1983 Sep; 31(5):657-63. PubMed ID: 6648898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Desensitisation in human and rabbit blood platelets.
    Hallam TJ; Ruggles PA; Scrutton MC; Wallis RB
    Thromb Haemost; 1982 Jun; 47(3):278-84. PubMed ID: 7112500
    [No Abstract]   [Full Text] [Related]  

  • 40. Sphingosine enhances platelet aggregation through an increase in phospholipase C activity by a protein kinase C-independent mechanism.
    Hashizume T; Sato T; Fujii T
    Biochem J; 1992 Feb; 282 ( Pt 1)(Pt 1):243-7. PubMed ID: 1540140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.